Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
SoftBank Acquires $5 Billion Stake in Roche
SoftBank has acquired a $5 billion stake in Swiss pharma giant Roche.
J&J notches a win in $50M talc lawsuit, but tens of thousands still pending
Johnson & Johnson notched a win Friday, with a $50 million talc lawsuit rejected in Illinois—however, tens of thousands of cases are still pending.
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc.
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa
LEXINGTON, Mass.
Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models
Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.
Sanofi bets on mRNA vaccines beyond COVID in $3.2 bln Translate Bio deal
PARIS, Aug 3 (Reuters) - Sanofi (SASY.
Chilean study shows variations in success of COVID-19 vaccines
SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.
Tecentriq wins FDA priority review for certain early NSCLC patients
The US Food and Drug Administration (FDA) has granted a priority review for Roche’s Tecentriq (atezolizumab) as an adjuvant treatment following surgery and platinum-based chemotherap...
Pfizer and Moderna raised their vaccine prices in their latest E.U contracts
Pfizer-BioNTech and Moderna both increased the price of their coronavirus vaccines in their latest contracts with the European Union, France’s minister for European affairs said on Monday.
Bristol Myers pulls an Istodax lymphoma use 10 years after FDA accelerated approval
Amid FDA pressure on immuno-oncology drugs that have failed confirmatory studies, Bristol Myers Squibb recently pulled two uses from Opdivo’s U.
As Veklury's sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs
The pandemic giveth, and the pandemic taketh away.
AstraZeneca’s FDA Approval Brings New Hope to the Lupus Community
Seventeen years after buying global rights, AstraZeneca is finally announcing a win for the lupus community with an FDA approval for Saphnelo.
209
210
211
212
213
214
215
216
217
